MicroRNA (miRNA) Market- Global Industry Analysis and Forecast (2023-2029)

MicroRNA (miRNA) Market is expected to reach US$ 647.63 Mn. at a CAGR of 11.6 % during the forecast period 2029. The report has analyzed the revenue impact of the COVID-19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis. MicroRNA (miRNA) MarketTo know about the Research Methodology :- Request Free Sample Report MicroRNA, also recognized as miRNA. It is a class of RNA that plays a vital role in the regulation of gene expression and is also involved in RNA silencing. MicroRNA is found in animals, plants, and some viruses. Generally, the development of well-organized and advanced technology, rise in consciousness, increasing focus on R&D, growing government initiative across the globe, development of molecular biology and genomic technologies, and growing government’s funding on healthcare are the major growth drivers of the global micro-RNA market. Growing number of patients suffering from cancer and other cardiovascular disorders, rising number of therapeutic applications, increasing adoption of the technology for use, reducing the cost of the sequencing are some of the factors which are driving the growth of the MicroRNA (miRNA) market in oncology in the forecast period (2023-2029). As well as, an increase in the adoption of micro-RNA in developing economies like China, India, and others, will create new opportunities for the global micro-RNA market. The high cost of kits and products with a lack of enhanced infrastructure are the restraints for the market growth of the MicroRNA (miRNA) market in oncology in the forecast period. The growing demand for skilled personnel along with challenges concerning in-house development of analysis which is the key challenge for the growth of the micro-RNA market. Existence of several companies, particularly domestic players creating massive price competition. Thermo Fisher Scientific Inc. is the leader in the global microRNA market in terms of revenue share in 2022, because of a varied product portfolio. Thermo Fisher Scientific Inc. also offers microRNA products exactly catering to the animal health and agriculture segment. Hence its wide product range providing to different end-users make it a market leader in the microRNA market. Illumina Inc., takings second position in the global microRNA market. The company has microarray kits and library preparation kits for miRNA. By End-use, Academic & government research institutes held the largest market share in the global market in 2022. This is mainly because of the rapid adoption of microRNA research tools by universities and research labs. The biotech & pharma companies segment is poised to post the highest CAGR in the forecast period, on account of the rapid adoption of research tools in the translation of scientific knowledge to clinical application. By region, North America held the largest market share of the global market in 2022, with approximately half of the world’s procedures being done in the U.S. because of high medical reimbursement facilities, support from the government, and technological advancement. Asia Pacific micro-RNA market is expected to grow with a significant pace, because of the fast increasing population, rise in consumer awareness, favorable government policies, modernization of healthcare infrastructure, and upward investments by the foreign countries in emerging countries such as China, and India in the APAC region. As well as, remarkable progress in genomic studies and the rising adoption of innovative technologies are expected to encourage the growth of the Asia Pacific market. For example, TaKaRa Bio, are involved in the development of products that consist of arrays and kits, so improving the growth of the APAC region. The objective of the report is to present a comprehensive analysis of the Global MicroRNA (miRNA) Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global MicroRNA (miRNA) Market dynamics, structure by analyzing the market segments and project the Global MicroRNA (miRNA) Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global MicroRNA (miRNA) Market make the report investor’s guide.

Scope of the Global MicroRNA (miRNA) Market: Inquire before buying

Global MicroRNA (miRNA) Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 300.38 Mn.
Forecast Period 2023 to 2029 CAGR: 11.6% Market Size in 2029: US $ 647.63 Mn.
Segments Covered: by Research Tools Services Products
by Application Cancer Infectious Diseases Immunological Disorder Cardiovascular Disease Neurological Disease Others
by End-use Biotechnology and Pharmaceutical Companies Academic & Government Research Institutes Others

Global MicroRNA (miRNA) Market, By Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Key players operating in the Global MicroRNA (miRNA) Market

1. Illumina, Inc. 2. F. Hoffmann-La Roche Ltd 3. Agilent Technologies 4. Bio-Rad Laboratories Inc. 5. Sigma Aldrich Corp. 6. Qiagen N.V 7. Thermo Fisher Scientific, Inc. 8. HTG Molecular Diagnostics, Inc. 9. Bioline GmbH (A Meridian Life Science Company) 10.Rosetta Genomics Ltd. 11.Dharmacon, a Horizon Discovery Group Co. 12.BioVendor — Laboratorní medicína a.s. 13.Miltenyi Biotec 14.Kaneka Corporation (Eurogentec) 15.Abcam Plc 16.GeneCopoeia, Inc. 17.Promega Corporation 18.New England Biolabs, Inc. 19.NanoString Technologies, Inc. 20.System Biosciences LLC 21.Others Frequently Asked Questions: 1. Which region has the largest share in Global MicroRNA (miRNA) Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global MicroRNA (miRNA) Market? Ans: The Global MicroRNA (miRNA) Market is growing at a CAGR of 11.6% during forecasting period 2023-2029. 3. What is scope of the Global MicroRNA (miRNA) market report? Ans: Global MicroRNA (miRNA) Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global MicroRNA (miRNA) market? Ans: The important key players in the Global MicroRNA (miRNA) Market are – Illumina, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Bio-Rad Laboratories Inc., Sigma Aldrich Corp., Qiagen N.V, Thermo Fisher Scientific, Inc., HTG Molecular Diagnostics, Inc., Bioline GmbH (A Meridian Life Science Company), Rosetta Genomics Ltd., Dharmacon, a Horizon Discovery Group Co., BioVendor — Laboratorní medicína a.s., Miltenyi Biotec, Kaneka Corporation (Eurogentec), Abcam Plc, GeneCopoeia, Inc., Promega Corporation, New England Biolabs, Inc., NanoString Technologies, Inc., System Biosciences LLC, and Others 5. What is the study period of this market? Ans: The Global MicroRNA (miRNA) Market is studied from 2022 to 2029.
1. MicroRNA (miRNA) Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. MicroRNA (miRNA) Market: Dynamics 2.1. MicroRNA (miRNA) Market Trends by Region 2.1.1. North America MicroRNA (miRNA) Market Trends 2.1.2. Europe MicroRNA (miRNA) Market Trends 2.1.3. Asia Pacific MicroRNA (miRNA) Market Trends 2.1.4. Middle East and Africa MicroRNA (miRNA) Market Trends 2.1.5. South America MicroRNA (miRNA) Market Trends 2.2. MicroRNA (miRNA) Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America MicroRNA (miRNA) Market Drivers 2.2.1.2. North America MicroRNA (miRNA) Market Restraints 2.2.1.3. North America MicroRNA (miRNA) Market Opportunities 2.2.1.4. North America MicroRNA (miRNA) Market Challenges 2.2.2. Europe 2.2.2.1. Europe MicroRNA (miRNA) Market Drivers 2.2.2.2. Europe MicroRNA (miRNA) Market Restraints 2.2.2.3. Europe MicroRNA (miRNA) Market Opportunities 2.2.2.4. Europe MicroRNA (miRNA) Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific MicroRNA (miRNA) Market Drivers 2.2.3.2. Asia Pacific MicroRNA (miRNA) Market Restraints 2.2.3.3. Asia Pacific MicroRNA (miRNA) Market Opportunities 2.2.3.4. Asia Pacific MicroRNA (miRNA) Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa MicroRNA (miRNA) Market Drivers 2.2.4.2. Middle East and Africa MicroRNA (miRNA) Market Restraints 2.2.4.3. Middle East and Africa MicroRNA (miRNA) Market Opportunities 2.2.4.4. Middle East and Africa MicroRNA (miRNA) Market Challenges 2.2.5. South America 2.2.5.1. South America MicroRNA (miRNA) Market Drivers 2.2.5.2. South America MicroRNA (miRNA) Market Restraints 2.2.5.3. South America MicroRNA (miRNA) Market Opportunities 2.2.5.4. South America MicroRNA (miRNA) Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For MicroRNA (miRNA) Industry 2.8. Analysis of Government Schemes and Initiatives For MicroRNA (miRNA) Industry 2.9. MicroRNA (miRNA) Market Trade Analysis 2.10. The Global Pandemic Impact on MicroRNA (miRNA) Market 3. MicroRNA (miRNA) Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 3.1.1. Services 3.1.2. Products 3.2. MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 3.2.1. Cancer 3.2.2. Infectious Diseases 3.2.3. Immunological Disorder 3.2.4. Cardiovascular Disease 3.2.5. Neurological Disease 3.2.6. Others 3.3. MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 3.3.1. Biotechnology and Pharmaceutical Companies 3.3.2. Academic & Government Research Institutes 3.3.3. Others 3.4. MicroRNA (miRNA) Market Size and Forecast, by Region (2022-2029) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America MicroRNA (miRNA) Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 4.1.1. Services 4.1.2. Products 4.2. North America MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 4.2.1. Cancer 4.2.2. Infectious Diseases 4.2.3. Immunological Disorder 4.2.4. Cardiovascular Disease 4.2.5. Neurological Disease 4.2.6. Others 4.3. North America MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 4.3.1. Biotechnology and Pharmaceutical Companies 4.3.2. Academic & Government Research Institutes 4.3.3. Others 4.4. North America MicroRNA (miRNA) Market Size and Forecast, by Country (2022-2029) 4.4.1. United States 4.4.1.1. United States MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 4.4.1.1.1. Services 4.4.1.1.2. Products 4.4.1.2. United States MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 4.4.1.2.1. Cancer 4.4.1.2.2. Infectious Diseases 4.4.1.2.3. Immunological Disorder 4.4.1.2.4. Cardiovascular Disease 4.4.1.2.5. Neurological Disease 4.4.1.2.6. Others 4.4.1.3. United States MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 4.4.1.3.1. Biotechnology and Pharmaceutical Companies 4.4.1.3.2. Academic & Government Research Institutes 4.4.1.3.3. Others 4.4.2. Canada 4.4.2.1. Canada MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 4.4.2.1.1. Services 4.4.2.1.2. Products 4.4.2.2. Canada MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 4.4.2.2.1. Cancer 4.4.2.2.2. Infectious Diseases 4.4.2.2.3. Immunological Disorder 4.4.2.2.4. Cardiovascular Disease 4.4.2.2.5. Neurological Disease 4.4.2.2.6. Others 4.4.2.3. Canada MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 4.4.2.3.1. Biotechnology and Pharmaceutical Companies 4.4.2.3.2. Academic & Government Research Institutes 4.4.2.3.3. Others 4.4.3. Mexico 4.4.3.1. Mexico MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 4.4.3.1.1. Services 4.4.3.1.2. Products 4.4.3.2. Mexico MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 4.4.3.2.1. Cancer 4.4.3.2.2. Infectious Diseases 4.4.3.2.3. Immunological Disorder 4.4.3.2.4. Cardiovascular Disease 4.4.3.2.5. Neurological Disease 4.4.3.2.6. Others 4.4.3.3. Mexico MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 4.4.3.3.1. Biotechnology and Pharmaceutical Companies 4.4.3.3.2. Academic & Government Research Institutes 4.4.3.3.3. Others 5. Europe MicroRNA (miRNA) Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 5.2. Europe MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 5.3. Europe MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 5.4. Europe MicroRNA (miRNA) Market Size and Forecast, by Country (2022-2029) 5.4.1. United Kingdom 5.4.1.1. United Kingdom MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 5.4.1.2. United Kingdom MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 5.4.1.3. United Kingdom MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 5.4.2. France 5.4.2.1. France MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 5.4.2.2. France MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 5.4.2.3. France MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 5.4.3. Germany 5.4.3.1. Germany MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 5.4.3.2. Germany MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 5.4.3.3. Germany MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 5.4.4. Italy 5.4.4.1. Italy MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 5.4.4.2. Italy MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 5.4.4.3. Italy MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 5.4.5. Spain 5.4.5.1. Spain MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 5.4.5.2. Spain MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 5.4.5.3. Spain MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 5.4.6. Sweden 5.4.6.1. Sweden MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 5.4.6.2. Sweden MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 5.4.6.3. Sweden MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 5.4.7. Austria 5.4.7.1. Austria MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 5.4.7.2. Austria MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 5.4.7.3. Austria MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 5.4.8.2. Rest of Europe MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 5.4.8.3. Rest of Europe MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 6. Asia Pacific MicroRNA (miRNA) Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 6.2. Asia Pacific MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 6.3. Asia Pacific MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 6.4. Asia Pacific MicroRNA (miRNA) Market Size and Forecast, by Country (2022-2029) 6.4.1. China 6.4.1.1. China MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 6.4.1.2. China MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 6.4.1.3. China MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 6.4.2. S Korea 6.4.2.1. S Korea MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 6.4.2.2. S Korea MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 6.4.2.3. S Korea MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 6.4.3. Japan 6.4.3.1. Japan MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 6.4.3.2. Japan MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 6.4.3.3. Japan MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 6.4.4. India 6.4.4.1. India MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 6.4.4.2. India MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 6.4.4.3. India MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 6.4.5. Australia 6.4.5.1. Australia MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 6.4.5.2. Australia MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 6.4.5.3. Australia MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 6.4.6. Indonesia 6.4.6.1. Indonesia MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 6.4.6.2. Indonesia MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 6.4.6.3. Indonesia MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 6.4.7. Malaysia 6.4.7.1. Malaysia MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 6.4.7.2. Malaysia MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 6.4.7.3. Malaysia MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 6.4.8. Vietnam 6.4.8.1. Vietnam MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 6.4.8.2. Vietnam MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 6.4.8.3. Vietnam MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 6.4.9. Taiwan 6.4.9.1. Taiwan MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 6.4.9.2. Taiwan MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 6.4.9.3. Taiwan MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 6.4.10.2. Rest of Asia Pacific MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 6.4.10.3. Rest of Asia Pacific MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 7. Middle East and Africa MicroRNA (miRNA) Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 7.2. Middle East and Africa MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 7.3. Middle East and Africa MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 7.4. Middle East and Africa MicroRNA (miRNA) Market Size and Forecast, by Country (2022-2029) 7.4.1. South Africa 7.4.1.1. South Africa MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 7.4.1.2. South Africa MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 7.4.1.3. South Africa MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 7.4.2. GCC 7.4.2.1. GCC MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 7.4.2.2. GCC MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 7.4.2.3. GCC MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 7.4.3. Nigeria 7.4.3.1. Nigeria MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 7.4.3.2. Nigeria MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 7.4.3.3. Nigeria MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 7.4.4.2. Rest of ME&A MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 7.4.4.3. Rest of ME&A MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 8. South America MicroRNA (miRNA) Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 8.2. South America MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 8.3. South America MicroRNA (miRNA) Market Size and Forecast, by End-use(2022-2029) 8.4. South America MicroRNA (miRNA) Market Size and Forecast, by Country (2022-2029) 8.4.1. Brazil 8.4.1.1. Brazil MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 8.4.1.2. Brazil MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 8.4.1.3. Brazil MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 8.4.2. Argentina 8.4.2.1. Argentina MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 8.4.2.2. Argentina MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 8.4.2.3. Argentina MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America MicroRNA (miRNA) Market Size and Forecast, by Research Tools (2022-2029) 8.4.3.2. Rest Of South America MicroRNA (miRNA) Market Size and Forecast, by Application (2022-2029) 8.4.3.3. Rest Of South America MicroRNA (miRNA) Market Size and Forecast, by End-use (2022-2029) 9. Global MicroRNA (miRNA) Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading MicroRNA (miRNA) Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Illumina, Inc. 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. F. Hoffmann-La Roche Ltd 10.3. Agilent Technologies 10.4. Bio-Rad Laboratories Inc. 10.5. Sigma Aldrich Corp. 10.6. Qiagen N.V 10.7. Thermo Fisher Scientific, Inc. 10.8. HTG Molecular Diagnostics, Inc. 10.9. Bioline GmbH (A Meridian Life Science Company) 10.10. Rosetta Genomics Ltd. 10.11. Dharmacon, a Horizon Discovery Group Co. 10.12. BioVendor — Laboratorní medicína a.s. 10.13. Miltenyi Biotec 10.14. Kaneka Corporation (Eurogentec) 10.15. Abcam Plc 10.16. GeneCopoeia, Inc. 10.17. Promega Corporation 10.18. New England Biolabs, Inc. 10.19. NanoString Technologies, Inc. 10.20. System Biosciences LLC 10.21. Others 11. Key Findings 12. Industry Recommendations 13. MicroRNA (miRNA) Market: Research Methodology 14. Terms and Glossary
  • INQUIRE BEFORE BUYING